holangiocarcinoma by modulating drugefflux pathways[J].Journal of Hepatology,2007,46(2):222229.
[4] Kato S,Ideguchi H,Muta K,et al.Machanisms involved in the development of adriamycin resistance in human leukemic cells [J].Leuk Res,1990,14(6):567573.
[5] Sandusky GE,Mintze KS,Pratt SE,et al.Expression of multidrug resistanceassociated protein 2(MRP2) in normal human tissues and carcinomas using tissue microarrays[J].Histopathology,2002,41(1):6574.
[6] Hinoshita E,Uchiumi T,Taguchi K,et al.Increased expression of an ATPbinding cassette superfamily transporter, multidrug resistance protein 2,in human colorectal carcinomas[J].Clin Cancer Res,2000,6(6):24012407.
[7]Suzuki H,Suqiyama Y.Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2 / ABCC2):its impact on drug disposition[J].Advanced Drug Delivery Review,2002，54(10):13111331.
[8] Liedert B,Materna V,Schadendorf D,et al.Overexpression of cMOAT (MRP2 /ABCC2) is associated with decreased formation of platinumDNA adducts and decreased G2arrest in melanoma cells resistant to cisplatin[J].J Invest Dermatol,2003,121 (1):172176.
[9] Chen ZS，Kawabe T，Ono M,et al.Effect of multidrug resistancereversing agents on transporting activity of human canalicular multispecific organic aniontransporter[J].Mol Pharmacol，1999,56(6):12191228.
[10]Koike K,Kawabe T,Tanaka T,et al.A canalicular multispecific organic anion transporter(cMOAT)antisense cDNR enhances drug sensitivity in human hepatic cancer cells[J].Cancer Res,1997，57(24)：54755479.
[11]Marienfeid C,Tadlock L,Yamagiway Y,et al.Inhibition of cholangiocarcinoma growth by tannic acid[J].Hepatology，2003，37(5):10971104.
[12]Yang EB,Wei L.Tannic acid,a potent inhibitor of epidermal growth factor receptor tyrosine kinase[J].J Biochem(Tokyo),2006，139(3):495502.
[13]Ikuta K,Takemura K,Sasaki K,et al.Expression of multidrug resistance proteins and accumulat
上一页 [1] [2] [3] [4] [5] [6] [7] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文